Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent NF1 Gene Variants and Correlations with Neurocognitive Phenotype

Genes (Basel). 2022 Jun 23;13(7):1130. doi: 10.3390/genes13071130.

Abstract

Neurofibromatosis type 1 (NF1) is one of the most common genetic tumor predisposition syndrome, caused by mutations in the NF1. To date, few genotype-phenotype correlations have been discerned in NF1, due to a highly variable clinical presentation. We aimed to study the molecular spectrum of NF1 and genotype-phenotype correlations in a monocentric study cohort of 85 NF1 patients (20 relatives, 65 sporadic cases). Clinical data were collected at the time of the mutation analysis and reviewed for accuracy in this investigation. An internal phenotypic categorization was applied. The 94% of the patients enrolled showed a severe phenotype with at least one systemic complication and a wide range of associated malignancies. Spine deformities were the most common complications in this cohort. We also reported 66 different NF1 mutations, of which 7 are novel mutations. Correlation analysis identified a slight significant inverse correlation between age at diagnosis and delayed acquisition of psychomotor skills with residual multi-domain cognitive impairment. Odds ratio with 95% confidence interval showed a higher prevalence of learning disabilities in patients carrying frameshift mutations. Overall, our results aim to offer an interesting contribution to studies on the genotype-phenotype of NF1 and in genetic management and counselling.

Keywords: NF1 mutational spectrum; Neurofibromatosis type 1; genotype-phenotype correlations; internal phenotypic categorization; monocentric study cohort; novel and recurrent NF1 mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genes, Neurofibromatosis 1
  • Genetic Association Studies
  • Humans
  • Neoplasm Recurrence, Local / genetics
  • Neurofibromatosis 1* / pathology
  • Neurofibromin 1
  • Phenotype

Substances

  • NF1 protein, human
  • Neurofibromin 1

Grants and funding

This research was funded by several scientific projects. F.N. is financed by the Italian Ministry of Health—Starting Grant-Ricerca Finalizzata 2018 (Project code: SG-2018-12367471; “Novel and non-invasive diagnostic and prognostic biomarkers for Neurofibromatosis type 1 and related cancers: expression profiling of serum circulating miRNAs and patho-physiological implications”). M.A.B.M. and S.S. thank the Regione Campania (RIS 3—POR FESR 2007/2013—Obiettivo 2.1, DIP. 54-DG 91 n. 403, 15/10/2015), Inter-University Center for Research in Neurosciences and University of Campania “Luigi Vanvitelli” (project V:ALERE 2019 Id343-TRANSITION “Nutri-epigenetics and physical activity: a natural help for Neurofibromatosis type 1”). M.A.B.M. is financed by Italian Ministry of Economic Development (MiSE)—Fund for Sustainable Development—Call “HORIZON2020” PON I&C 2014–2020, FOR.TUNA project, code No. F/050347/01_03/X32. S.P. thanks the POR Campania FESR 2014–2020 “SATIN” grant.